U.S., Sept. 10 -- An application to own the trademark for 'MYO TECHNOLOGY' has been filed on Dec. 30, 2024.
Owner(s):
RENBIO, INC.; 30-02 48TH Avenue, Suite 340, NEW YORK
Goods and/or Services:
For: Pharmaceutical preparations containing nucleic acid sequences that encode monoclonal antibodies for the treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Pharmaceutical compositions for the prevention and treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Nucleic acid sequences for medical purposes; Pharmaceutical compositions, namely, a nucleotide sequence that encodes an antigen, such as a DNA plasm...